Published: 2020-06-25

The role of Helicobacter pylori in preeclampsia and in gastric diseases in pregnant women

Jehan Sabah Hasan, Mohammed Ahmed Alshami


Background: Helicobacter pylori is a gastric organism was first observed more than 100 years ago. It may cause chronic gastritis, peptic ulcers and gastric adenocarcinoma and lymphoma. It can produce some extragastric disorders including preeclampsia. This study aimed to focus on the importance of H. pylori and its relationship with preeclampsia and gastric illnesses in pregnant patients.

Methods: This study includeed 100 pregnant women, half of them were healthy and the other half with preeclampsia. Patients with chronic medical illnesses were excluded. Data was collected and laboratory investigations were done including that for H. pylori. Oesophagogastroduodenoscopy then was done 6 weeks post-delivery or termination of pregnancy for symptomatic H. pylori positive women.

Results: 50% of the total number were healthy, 17% had mild preeclampsia, 33% suffering from severe preeclampsia. Seropositivity for H. pylori is significantly higher in preeclampsia and significantly related to severity of preeclampsia and complications of pregnancy. Positive H. pylori test in stool was seen in (45%) of total number of patients. Epigastric pain persist in 41 (91%) of patients with positive H. pylori test in stool. Gastritis, duodenal ulcer, and gastric ulcer were found in 85.3%, 12.1% and 2.4% of symptomatic patients respectively.

Conclusions: Significant correlation between Helicobacter pylori seropositivity and preeclampsia may indicate the benefit of using this parameter in the prediction and management of preeclampsia and its severity. H. pylori infection plays an important role in gastric pathologies in pregnant women that can be dealt with or may be prevented more efficiently in future.



Preeclampsia, H. pylori, Gastric

Full Text:



Graham DY. History of Helicobacter pylori, duodenal ulcer, gastric ulcer and gastric cancer. World J Gastroenterol. 2014;20(18):5191-204.

Kivi M, Johansson AL, Reilly M, Tindberg Y. Helicobacter pylori status in family members as risk factors for infection in children. Epidemiol Infect. 2005;133:645.

Ehab HN, Ghada MM. Helicobacter pylori and Hyperemesis Gravidarum. Nature Sci. 2010;8(8):44-9.

Amieva MR, El-Omar EM. Host-bacterial interactions in Helicobacter pylori infection. Gastroenterol. 2008;134:306.

Gasbarrini G, Racco S, Franceschi F, Miele L, Cammarota G, Grieco A, et al. Helicobacter pylori infection: from gastric to systemic disease. Recenti Prog Med. 2010;101(1):27-33.

Xia HH, Lam SK, Chan AO, Lin MC, Kung HF, Ogura K, et al. Macrophage migration inhibitory factor stimulated by Helicobacter pylori increases proliferation of gastric epithelial cells. World J Gastroenterol. 2005;11:1946-50.

Cardaropoli S, Rolfo A, Piazzese A, Ponzetto A, Todros T. Helicobacter pylori's virulence and infection persistence define pre-eclampsia complicated by fetal growth retardation. World J Gastroenterol. 2011;17(47):5156-65.

Bellack NR, Koehoorn MW, MacNab YC, Morshed MG. A conceptual model of water's role as a reservoir in Helicobacter pylori transmission: a review of the evidence. Epidemiol Infect. 2006;134:439.

Gravina AG, Zagari RM, De Musis C, Romano L, Loguercio C, Romano M. Helicobacter pylori and extragastric diseases: a review. World J Gastroenterol. 2018;24(29):3204-21.

Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, et al. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994;71:437-9.

Mayburry M, Waugh J. Proteinuria in pregnancy. Fetal Andmaternal Med Review. 2004;16:71-95.

Duckitt K, Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ. 2005;330:565.

Kenny LC, Myers J. Epidemiology of preeclampsia. In Obstetrics by ten teachers. 19th edition. Hodder Arnold. 2011: 122.

Mustafa R, Ahmed S, Gupta A. Rocco C, Venuto A. Comprehensive review of hypertension in pregnancy. J Preg. 2012;5:105918.

Sibai BM, Mercer B, Sarinoglu C. Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol. 1991;165:1408.

Ponzetto A, Cardarpoli S. Preeclampsiais associated with H pylori seropositivity in Italy. J Hypertens. 2006;24:2445-9.

Hauth JC, Ewell MG, Levine RJ. Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for preeclampsia prevention study group. Obstet Gynecol. 2000;95:24.

Norwitz ER, Hsu CD, John T. Acute complications of preeclampsia. Clin Obst Gynecol. 2002;45(2):308-29.

Aqudelo C, Villar J. Maternal infection and risk factor of preeclampsia systemic review. Am J Obst Gyn. 2008;198(1):7-22.

Tytgat GN. Endoscopic transmission of Helicobacter pylori. Aliment Pharmacol Ther. 1995;9(2):105.

Shiadeh MN, Riahi SM, Adam I, Saber V, Behboodi Z. Armon B. Helicobacter pylori infection and risk of preeclampsia: a systematic review and meta-analysis. J Maternal-Fetal Neonatal Med. 2019;32(2):324-31.

Trogstad LIS, Eskild A, Bruu AL, Jeansson S, Jenum PA. Is preeclampsia an infectious disease? Acta Obstet Gynecol Scand. 2001;80:1036-8.

Todros T, Verdiglione P, Ogge G, Paladini D, Vergani P, Cardaropoli S. Low incidence of hypertensive disorders of pregnancy in women treated with spiramycin for toxoplasma infection. Br J Clin Pharmacol. 2006;336:340-61.

Oung B, Chea K, Oung C, Saurin JC, Ko CW. Endoscopic yield of chronic dyspepsia in outpatients: a single-center experience in Cambodia. JGH Open. 2020;4(1):61-8.